News Conference News AHA 2017 Patients Commonly Get High Radiation Doses During CTO PCI Todd Neale November 20, 2017
News Conference News AHA 2017 RE-DUAL PCI Findings Consistent Across Key Subgroups Todd Neale November 16, 2017
News Conference News AHA 2017 Survey Says: Interventionalists Believe Public Reporting Leads to High-Risk PCI Avoidance, Upcoding Yael L. Maxwell November 15, 2017
News Conference News AHA 2017 ‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18 Michael O'Riordan November 15, 2017
News Conference News AHA 2017 Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality Michael O'Riordan November 14, 2017
News Conference News AHA 2017 Aspirin Protective Against Early Death/MI in Prior PCI Patients Undergoing Noncardiac Surgery Shelley Wood November 14, 2017
News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017
Presentation AHA 2017 Subgroup Analysis from the RE-DUAL PCI Trial Presenter: Jonas Oldgren November 14, 2017
News Conference News AHA 2017 Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation Michael O'Riordan November 13, 2017
News Conference News AHA 2017 Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List Michael O'Riordan November 12, 2017
News Conference News AHA 2017 Better PCI Outcomes Not Guaranteed at Top-Ranked Hospitals Todd Neale November 12, 2017
News Conference News AHA 2017 AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More Shelley Wood November 09, 2017